Utah Medical Products reports Q3 2023 results; financial data not provided in excerpt

UTAH MEDICAL PRODUCTS INC

2023-Q3 EPS reported $3.39 revenue$37,891,000

Press release dated October 26, 2023 covers three and nine months ended September 30, 2023.
Exhibit 99.1 with specific financial figures was not included in the user query.
No revenue, EPS, or segment details available for summary.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.